期刊文献+

氯沙坦治疗老年人心房颤动的临床观察 被引量:1

下载PDF
导出
摘要 目的观察氯沙坦与胺碘酮联合应用对老年患者持续性心房颤动(房颤)的临床疗效。方法选择老年持续性房颤患者62例,随机分为2组,对照组30例应用胺碘酮口服治疗,治疗组32例应用胺碘酮+氯沙坦口服治疗,观察2组的复律成功率及治疗后12个月内的窦性心律维持率,并测量复律成功即刻、复律后12个月的左心房直径。结果治疗组复律成功率(68%)明显高于对照组(41%),P<0.05,治疗9个月后治疗组窦性心律维持率显著高于对照组,治疗组治疗后12个月左心房直径(3.53±0.17)cm小于对照组((3.72±0.25)cm),P<0.05。结论氯沙坦能有效改善胺碘酮对老年患者持续性房颤的转复率及窦性心律维持率,并能抑制左心房的扩大。
作者 颜安华
出处 《现代中西医结合杂志》 CAS 2008年第5期685-686,共2页 Modern Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献8

  • 1Heidbuchel H. A paradigm shift in treatment for atrial fibrillation: form electrical to structural therapy [J ]. Eur Heart J, 2003,24 (23) :2007 - 2078.
  • 2Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation. Time course and mechaniams[J ]. Circulation, 1996,94 (11):2968 -2974.
  • 3Finkielstein D, Schweitzer P. Role of angiotension-converting anzyme inhibitors in the prevention of atrial fibrillation [ J ]. Am J Cardiol,2004,93(6) ;734-736.
  • 4Goette A,Staack T,Rocken C,et al. Increased expression of extracellular signal-regulated kinase and angiotension-converting enzyme in human atria duing atrial fibrillation [ J ]. J Am Coll Cardiol, 2000,35(6) :1669 - 1677.
  • 5Maggioni AP, Latini R, Carson PE, et al. Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trail ( Val - HEFT) [ J ]. Am Heart J,2005,149(3) :548 - 557.
  • 6Lindholm LH, Ibsen H, Dahlof B, et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol [ J ]. Lancet, 2002,359 (9311) : 1004 - 1010.
  • 7Madrid AH, Bueno MG, Rebollo JM, et al. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation a prospective and randomized study [ J ]. Circulation, 2002,106(3) :331 - 336.
  • 8殷跃辉,刘增长,杨小渝,董军,高大中,佘强,熊杰熙,黄祖荣.小剂量胺碘酮与培哚普利联合治疗阵发性心房颤动的临床疗效[J].中国循环杂志,2004,19(1):19-21. 被引量:45

二级参考文献12

  • 1[1]Roy D,Talajic M,Dorian P, et al. Amiodarnoe to prevent recurrence of atrial fibrillation. Canadian Trial of atrial fibrillation Investigators. N Engl J Med, 2000,342: 913-920.
  • 2[2]Kochiadakis GE, Igoumenidis NE, Marketou ME, et al. Low-dose amiodarone versus sotalol for suppression of recurrent symptomatic atrial fibrillation. Am J Cardiol, 1998,81:995-998.
  • 3[3]Wijffels MCEF, Kirchhof CJHJ, Dorland R, et al. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation, 1995,92:1954-1968.
  • 4[4]Goette A, Honeycutt C,Langberg JJ. Electrical remodeling in atrial fibrillation: time course and mechanisms. Circulation, 1996, 94: 2968-2974.
  • 5[5]Tieleman RG, Langen CDJD, Gelder ICV, et al. Verapamil reduces tachycardia-induced electrical remodeling of the atria. Circulation, 1997,95:1945-1953.
  • 6[6]Wijffels MCEF, Kirchhol CJHJ, Dorland R, et al. Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats:role of neurohumoral changes,ischemia,atrial stretch,and high rate of electrical activation. Circulation, 1997,96: 3710-3720.
  • 7[7]Tieleman RG, Gelder ICV, Crijns HJGM, et al. Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-reduced electrical remodeling of atria? J Am Coll Cardil, 1998,31:167-173.
  • 8[8]Van Den Berg MP, Crijns HJGM, Van Veldhuisen DJ, et al. Effects of lisinopril in patients with heart failure and chronic atrial fibrillation. J Card Fail, 1995,1: 355-364.
  • 9[9]Hideko N, Koickiro K, Hidenori U, et al. Angiotensin Ⅱ antagonist prevents electrical remodeling in atrial fibrillation. Circulation, 2000, 101:2612-2617.
  • 10[10]Goette A, Amdt M, Rocken C, et al. Regulation of angiotensin Ⅱ receptor subtypes during atrial fibrillation in human. Circulation, 2000,101:2678-2681.

共引文献44

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部